A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department (T2I)
Texting 2 Initiate: A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department (T2I)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Manhattan, New York, United States, 10032
- Morgan Stanley Children's Hospital Emergency Department
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 14-19 years
- Sexually active with males in the past three months
- Presenting to the ED for a reproductive health complaint.
Exclusion Criteria:
- Presently pregnant
- Too ill for participation per the attending physician
- Cognitively impaired
- In foster care or a ward of the state
- Does not speak English or Spanish
- Does not own a cellular or mobile phone with text messaging capabilities
- Used contraception at last intercourse and/or is currently using any "highly effective" or "effective" form of contraception (as defined by the World Health Organization)
- Does not live in Manhattan or the Bronx
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Text Messaging Intervention
Patients in the text messaging group will receive educational and motivational text messages.
|
|
|
Active Comparator: Standard Referral
Patients in the standard referral arm will receive paper based information about the Family Planning Clinic.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Initiation of highly effective contraception, as defined by the World Health Organization.
Time Frame: 3 months after initial enrollment
|
We will be assessing contraception initiation rates based on electronic medical record review and telephone call follow up.
|
3 months after initial enrollment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient visits to Family Planning Clinic
Time Frame: 3 months after initial enrollment
|
We assess Family Planning Clinic visits using our electronic medical records.
|
3 months after initial enrollment
|
|
Follow up for contraceptive counseling to a doctor or nurse
Time Frame: 3 months after initial enrollment
|
We will be asking patients during our phone call follow if they have had contraceptive counseling with any healthcare professional.
We will also be looking through electronic medical records for documentation of contraceptive counseling such as by ICD-9 coding or a physician's/nurse's note.
|
3 months after initial enrollment
|
|
Change in pregnancy intentions
Time Frame: 3 months after initial enrollment
|
We will compare pregnancy intentions elicited from the answers provided in the baseline questionnaire to those reported on the telephone follow up for both study arms.
|
3 months after initial enrollment
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Text messaging intervention safety
Time Frame: 3 months after initial enrollment
|
Safety will be assessed during the telephone follow up.
|
3 months after initial enrollment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Lauren Chernick, MD, Columbia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AAAM3457
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.